Bayesian prediction
clinical trials
Monte-Carlo simulations
exponential models
stopping rule

How to Cite

Djeridi, Z., & Merabet, H. (2019). A BAYESIAN PREDICTIVE PROCEDURE FOR TWO STEPS EXPERIMENTAL TRIALS. Journal of Sciences & Technology , 4(1). Retrieved from http://revue.umc.edu.dz/index.php/st/article/view/3115


Bayesian predictive procedures give the researcher a very appealing method to evaluate the chances that the experiment will end up showing a conclusive result, or on the contrary an inconclusive one. The prediction can be explicitly based on either the hypothesis used to monitor the experiment expressed either in terms of prior distribution, on partially available data, or on both. In this paper, we propose a Bayesian predictive methodology based on two steps which can be used to develop an adaptive design for the experimental trials. This procedure does not require intensive computation and comprehensive simulations. We have used the non-informative prior to give evidence on the objectivity of the experimental data.


Berger, J.O. and Sellke, T. (1987). Testing a Point Null Hypothesis: The Irreconcilability of P Values and Evidence.. Journal of the American Statistical Association, Vol. 82, No. 397, 112-122.

Chow, S. C. (2005). Statistical consideration of adaptive methods in clinical development. Journal Biopharm. Stat., 15, 575-91.

Chow, S. C., Berry, S.M., Carlin, B.P., Lee, J.J., Müller, P. (2011). Bayesian adaptive methods for clinical trials. Chapman &Hall/CRC Press, New York.

Chow, S. C. Corey, R., Lin, M., (2012). On the independence of data monitoring committee in adaptive design clinical trials. Journal of biopharmaceutical statistics, 22(4): 853-867.

Chow, S. C. and Chang M., (2007). Adaptive design in clinical trials. Chapman & Hall/CRC. Biostatistics Series, USA.

Djeridi, Z. Merabet, H., (2016). Choice of the prior in the Bayesian design for the clinical trials . Sciences et Technologie: A , N44, 27-31.

Goodman S., (2008). A Dirty Dozen: Twelve P-Value Misconceptions. In Siminar in Hematologie, 45: 135-140.

Guosheng, Y. Chen, C., Lee, J.J. (2012). Phase II trial design with Bayesian adaptive randomization and predictive probability. statistical society: Series C (Applied statistics), 61, 219-235.

Hamada, M. S., Wilson, A.G., Reese, C. S., Martz, H.F., (2008). Bayesian reliability. Springer Series in statistics.

Hoff, P.D., (2009). A first course in Bayesian statistical Methods. Springer science + Business media, New York.

Hwang, J.T., Casela, G., Robert, C., Wells, M.T., Farrell, R.H., (1992). Estimation of accuracy in testing. The annals of statistics, Vol. 20, No. 1; 490-509.

Lecoutre, B, (2001). A Bayesian predictive procedures for designing and monitoring experiments. In Bayesian methods with applications to science, Policy and official statistics Luxemburg. office for official publications of the european communities, 301-310.

Lecoutre, B., Derzko, G. and Grouin, J. M., (1995). Bayesian predictive approach for inference about proportions. Statistics in Medecine, 14: 1057- 1063.

Lee, J.J. and Liu, D.D., (2008). A predictive probability design for phase II cancer clinical trials. Clinical Trials, 5: 93-106.

Merabet, H., (2004). Index and prevision of satisfaction in exponential models for clinical trials. Statistica, anno LXIV, n3, 441-453.

Merabet, H., Labdaoui, A., (2015). Bayesian prediction using two stages design in expiremental trials. Nature & Technologie A-Sciences fondamentals et engineering, n 12: 11-23.

Robert, C.P., (2007). Bayesian choice.From Decision-Theoretic Foundations to Computational Implementation. Springer science + Business media, New York.

Saville, B. R. , Connor, J. T. , Ayers, G. D. and Alvarez, J., (2014). The utility of Bayesian predictive probabilities for interim monitoring of clinical trials. Clin Trials,DOI: 10.1177/1740774514531352.

Shao,Y., Mukhi, V., and Goldberg, J. D., (2008). A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority. Statist. Med., 27:504-519.

Simon, R., (1989). Optimal two-stage design for phase II clinical trials. Controlled clinical trials, 10: 1-10.


Download data is not yet available.